You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The closing range uses available history since Aug 18, 2026; less than a full year is stored.
On October 30, 2026, NorthStrive Acquisition Corp I. entered a business combination agreement with Nuclea Energy Inc., setting a US$350.0 million base company valuation subject to adjustments and earnouts tied to reactor criticality, licensing and US$100,000,000 in funding.
Illustrative technical + ownership context — a signal mix, not investment advice.
| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
NSAIU
this stock
NorthStrive Acquisition Corp I.
|
$143.02M | — | — | — | — |
|
VYLR
Vylor Inc.
|
$48.01B | — | — | — | 2.2% |
|
CLUS
Cluster Group Holdings Ltd Co
|
$8.00B | — | — | — | — |
|
DMII
Drugs Made In America Acquisition II Corp.
|
$650.38M | +3.3% | — | — | 0.0% |
|
EVAC
EQV Ventures Acquisition Corp. II
|
$606.10M | +3.4% | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
On October 30, 2026, NorthStrive Acquisition Corp I. entered a business combination agreement with Nuclea Energy Inc., setting a US$350.0 million base company valuation subject to adjustments and earnouts tied to reactor criticality, licensing and US$100,000,000 in funding.
View| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| NSAIU | +0.3% | +0.6% | — | +0.0% | — |
| SPY | -1.7% | -2.9% | +1.9% | -0.5% | +10.3% |
| vs SPY | +2.0% | +3.5% | — | +0.5% | — |
